Alvarez-Larrán et al. 1 in their reply letter state that Polycythaemia Vera Study Group criteria are currently used for the diagnosis of chronic myeloproliferative disorders and quote two important publications. Both these publications are recent; however, Carobbio et al. Alvarez-Larrán et al. are somewhat inconsistent using WHO criteria for diagnosis of primary myelofibrosis in their study but not for essential thrombocythaemia. The fibrosis grading system in their publication 5 does not include collagen deposition and is divergent with the current grading system. 6 It is interesting to learn that with substantial follow-up (10 years) that myelofibrosis did not develop despite moderate fibrosis in these 20 essential thrombocythaemia patients. There is no doubt that there is considerable difficulty in distinguishing essential thrombocythaemia from early-phase chronic idiopathic myelofibrosis/primary myelofibrosis. For the time being we will have to accept a disagreement in utilization of classification systems.
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